JS-K Reduces Breast Cancer Cell Invasion
Author Information
Author(s): Simeone Ann-Marie, McMurtry Vanity, Nieves-Alicea René, Saavedra Joseph E, Keefer Larry K, Johnson Marcella M, Tari Ana M
Primary Institution: The University of Texas MD Anderson Cancer Center
Hypothesis
Does the nitric oxide-releasing prodrug JS-K inhibit breast cancer cell invasion?
Conclusion
JS-K inhibits breast cancer invasion across the Matrigel basement membrane, and this effect is mediated by increased TIMP-2 production.
Supporting Evidence
- JS-K significantly decreased the invasiveness of breast cancer cells across the Matrigel basement membrane.
- JS-K increased TIMP-2 production, which is crucial for its anti-invasive effects.
- Blocking TIMP-2 activity reduced the effectiveness of JS-K in inhibiting cell invasion.
Takeaway
JS-K is a special drug that helps stop breast cancer cells from spreading by making a protein called TIMP-2 that keeps the cells from invading other areas.
Methodology
The study used breast cancer cell lines and assessed the effects of JS-K on cell invasion and TIMP-2 production through various assays.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website